Clinical Trial: A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801027) titled 'A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)' on Aug. 28.

Brief Summary: The goal of this study is to assess the safety of pembrolizumab with chemotherapy or chemoradiotherapy in participants in India for:

* Advanced gastric or gastroesophageal junction [GEJ] cancer that is (human epidermal growth factor receptor 2 [HER2]-negative and has a programmed death-ligand 1 [PD-L1] combined positive score [CPS] >=1

* Advanced and/or unresectable biliary tract cancer [BTC], and

* High-risk, locally advanced cervical cancer

Study Start D...